Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 25 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
451 N Texas Ave
Webster, TX 77598Phone+1 281-333-2288Fax+1 281-335-4605- Is this information wrong?
Summary
- Dr. Patricia Lee, MD is a dermatologist in Webster, Texas. She is currently licensed to practice medicine in Texas and Alabama. She is affiliated with HCA Houston Healthcare Clear Lake and St. Luke's Health - Baylor St. Luke's Medical Center.
Education & Training
- University of Alabama Medical CenterFellowship, Dermatopathology, 1985 - 1987
- University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 1981 - 1985
- McGovern Medical School at UTHealthClass of 1981
Certifications & Licensure
- TX State Medical License 1985 - 2026
- AL State Medical License Active through 1991
- American Board of Pathology Anatomic Pathology
Clinical Trials
- A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 15 citationsSpesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, plac...Robert Bissonnette, William Abramovits, Étienne Saint-Cyr Proulx, Patricia Lee, Emma Guttman-Yassky, Elizabeta Zovko, Ralf Sigmund, Joanne Willcox, Thomas Bieber> ;Journal of the European Academy of Dermatology and Venereology. 2023 Mar 1
- 6 citationsEfficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque...Andrew Blauvelt, Kenneth B. Gordon, Patricia C. Lee, Jerry Bagel, Howard Sofen, Benjamin Lockshin, Ahmed M. Soliman, Ziqian Geng, Tianyu Zhan, Gabriela Alperovich, Lin...> ;The Journal of Dermatological Treatment. 2021 May 5
- 4 citationsEfficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse...Wendy Cantrell, P. Lee, Alan M. Mendelsohn, Stephen J. Rozzo, Wilson Liao> ;Journal of the European Academy of Dermatology and Venereology. 2021 Feb 12
Hospital Affiliations
- HCA Houston Healthcare Clear LakeLeague City, Texas
- St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas